[
  {
    "ticker": "TIP",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971725",
    "id": "02971725",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0847",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1nk6nrvmybg.pdf",
    "summary": "<ul>\n<li><strong>Buy-back type</strong>: On-market buy-back  </li>\n<li><strong>Total shares bought back as of 22/7/2025</strong>: 73,664 (67,917 before + 5,747 on previous day)  </li>\n<li><strong>Remaining buy-back capacity</strong>: 2,626,419 shares (out of 2,700,083 maximum)  </li>\n<li><strong>Buy-back period</strong>: 14/4/2025 to 14/4/2026  </li>\n<li><strong>Recent buy-back details (22/7/2025)</strong>:  </li>\n<li>Volume: 5,747 shares  </li>\n<li>Total cost: AUD 9,999.78  </li>\n<li>Price: AUD 1.74 (flat for the day)  </li>\n<li><strong>Highest price paid (historical)</strong>: AUD 1.85 (20/5/2025)  </li>\n<li><strong>Broker executing buy-back</strong>: Phillip Securities (AUS) Limited  </li>\n</ul>\n<p><em>No material operational/financial impacts identified beyond buy-back execution.</em></p>",
    "usage": {
      "prompt_tokens": 1529,
      "completion_tokens": 204,
      "total_tokens": 1733,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:52:08.231549"
  },
  {
    "ticker": "RMI",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971724",
    "id": "02971724",
    "pages": 5,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0846",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1nh1n4nky2j.pdf",
    "summary": "<ul>\n<li><strong>Drilling commenced</strong> at Mpanda Copper-Gold Project (Tanzania):  </li>\n<li>1,000m RAB drilling underway at Stalike (40m depth target) and Kabungu (30m depth target) prospects.  </li>\n<li>\n<p>Assays pending for gold, copper, and other elements (1m samples, 2m composites).  </p>\n</li>\n<li>\n<p><strong>Third-party interest</strong> reported for Mpanda exploration/development and Tanzanian nickel assets.  </p>\n</li>\n</ul>\n<p><em>No material financial, capital structure, or trading-specific information identified.</em></p>",
    "usage": {
      "prompt_tokens": 2556,
      "completion_tokens": 112,
      "total_tokens": 2668,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:53:13.158430"
  },
  {
    "ticker": "PER",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971723",
    "id": "02971723",
    "pages": 3,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0846",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1ndzwshmjyk.pdf",
    "summary": "<h3>Key Material Information:</h3>\n<ul>\n<li><strong>Preclinical Data Update</strong>:  </li>\n<li>HMBD-002 combined with <strong>radiotherapy</strong> showed improved efficacy in mouse models of <strong>squamous cell carcinoma of the head and neck (SCCHN)</strong>, increasing median survival to <strong>35.5 days vs. 27 days</strong> (radiotherapy alone).  </li>\n<li>\n<p>Potential <strong>new clinical pathway</strong> for HMBD-002 as a VISTA inhibitor to enhance radiotherapy efficacy in SCCHN, breast cancer, and melanoma.  </p>\n</li>\n<li>\n<p><strong>Development Implications</strong>:  </p>\n</li>\n<li>Data supports <strong>future clinical trials</strong> combining HMBD-002 with radiotherapy, but no definitive decision yet. Target timeline for next trials: <strong>CY2026</strong>.  </li>\n</ul>\n<p><em>No capital markets or trading-specific actions identified.</em></p>",
    "usage": {
      "prompt_tokens": 1540,
      "completion_tokens": 158,
      "total_tokens": 1698,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:52:20.389552"
  },
  {
    "ticker": "CHM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971721",
    "id": "02971721",
    "pages": 11,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0845",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1n8l91l4pnt.pdf",
    "summary": "<ul>\n<li><strong>Clinical Trial Updates:</strong>  </li>\n<li><strong>CHM CDH17 CAR-T Trial:</strong>  <ul>\n<li>5 patients treated (Dose Level 1 completed, Dose Level 2 commenced).  </li>\n<li>2/4 patients showed stable disease (6 months for one, day 150 for another).  </li>\n<li>8/8 successful GMP manufacturing runs.  </li>\n</ul>\n</li>\n<li>\n<p><strong>CHM CORE-NK Trial:</strong>  </p>\n<ul>\n<li>Dose-finding completed; frontline AML trial commenced.  </li>\n<li>2/3 patients achieved CRi (complete response with incomplete blood recovery).  </li>\n<li>No dose-limiting toxicities or cytokine release syndrome observed.  </li>\n</ul>\n</li>\n<li>\n<p><strong>Capital &amp; Corporate:</strong>  </p>\n</li>\n<li><strong>$16.6m raised</strong> (includes $5.6m from US Family Office).  </li>\n<li>Lind facility repaid in full by July 2025.  </li>\n<li>\n<p>Significant cost reductions implemented.  </p>\n</li>\n<li>\n<p><strong>Financial Position:</strong>  </p>\n</li>\n<li>Market cap: ~$1.6B (share price: $0.005, 52-week range: $0.004\u2013$0.047).  </li>\n<li>\n<p>Cash balance not explicitly stated (likely covered under capital raise).  </p>\n</li>\n<li>\n<p><strong>Portfolio:</strong>  </p>\n</li>\n<li>4 active Phase 1 trials across novel cell therapies.  </li>\n<li>Unique CDH17 CAR-T candidate (only one in clinical trials).  </li>\n</ul>\n<p><strong>Omitted:</strong> Forward-looking statements, disclaimers, non-material operational details.</p>",
    "usage": {
      "prompt_tokens": 1515,
      "completion_tokens": 300,
      "total_tokens": 1815,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:49:57.763416"
  },
  {
    "ticker": "QFE",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971720",
    "id": "02971720",
    "pages": 7,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0845",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1n6hgfpd39p.pdf",
    "summary": "<ul>\n<li><strong>Capital Raising Type</strong>: Placement (Tranche 2)  </li>\n<li><strong>Total Securities Issued</strong>: 7,180,000 ordinary shares  </li>\n<li><strong>Issue Price</strong>: AUD 0.05 per share  </li>\n<li><strong>Issue Date</strong>: 25 July 2025  </li>\n<li><strong>Recipients</strong>: Entities controlled by directors (Dale Smorgon, Bruce Coombes, Michael McConnell)  </li>\n<li><strong>Shareholder Approval</strong>: Obtained on 22 July 2025 (ASX Listing Rule 10.11)  </li>\n<li><strong>Post-Issue Issued Capital</strong>: 372,481,758 ordinary shares (quoted) + various unquoted options/warrants  </li>\n</ul>\n<p><em>(Note: No new capital raised as this is a quota application for shares issued under a previously announced placement.)</em></p>",
    "usage": {
      "prompt_tokens": 1902,
      "completion_tokens": 164,
      "total_tokens": 2066,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:53:51.622859"
  },
  {
    "ticker": "TTX",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971722",
    "id": "02971722",
    "pages": 11,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0845",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1nbnjz36c20.pdf",
    "summary": "<h3><strong>Tetratherix Limited (ASX: TTX) \u2013 Material Information Summary</strong></h3>\n<h4><strong>1. License Agreement with BioOptix Inc.</strong></h4>\n<ul>\n<li>Exclusive licensing deal to develop/commercialize ophthalmic viscoelastic device (OVD).  </li>\n<li>Tetratherix becomes minority shareholder in BioOptix.  </li>\n<li>BioOptix funds FDA regulatory approvals; Tetratherix to manufacture (minimum 1M units for first 5 years post-commercialization).  </li>\n<li>Licensing income expected from FY26.  </li>\n</ul>\n<h4><strong>2. Tutelix FDA Progress (50% JV)</strong></h4>\n<ul>\n<li>FDA pre-submission completed; product classified as <strong>Class II</strong> device.  </li>\n<li><strong>510(k) clearance on track for FY28</strong>, clinical trial design confirmed.  </li>\n</ul>\n<h4><strong>3. ASX Listing &amp; Capital Raising</strong></h4>\n<ul>\n<li><strong>IPO raised $25M</strong> (primary capital) at <strong>$2.88/share</strong>, market cap <strong>$145M</strong>.  </li>\n<li><strong>Closing cash: $29.3M</strong> (no debt).  </li>\n</ul>\n<h4><strong>4. Financials (Appendix 4C Highlights)</strong></h4>\n<ul>\n<li><strong>Q4 cash outflow: $3.9M</strong> (IPO costs, R&amp;D).  </li>\n<li><strong>Cash balance: $29.3M</strong> (inline with prospectus forecasts).  </li>\n</ul>\n<h4><strong>5. Near-Term Catalysts</strong></h4>\n<ul>\n<li><strong>Tutelix FIH trial</strong> (Q1/Q2 FY26).  </li>\n<li><strong>FDA 510(k) clearances for Tegenix/TegeEOS</strong> (target H2 FY26).  </li>\n<li><strong>TetraDerm Phase 2 recruitment</strong> (face/neck incisions).  </li>\n</ul>\n<p><strong>No material information omitted.</strong></p>",
    "usage": {
      "prompt_tokens": 5306,
      "completion_tokens": 349,
      "total_tokens": 5655,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:49:35.233680"
  },
  {
    "ticker": "PDN",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971717",
    "id": "02971717",
    "pages": 20,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0843",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1mzxwtsh0zx.pdf",
    "summary": "<p>Here\u2019s the material information extracted from the Paladin Energy June 2025 Quarterly Presentation, formatted concisely for capital markets decisions:</p>\n<h3><strong>Operational Highlights</strong></h3>\n<ul>\n<li><strong>Production</strong>: Q4 U\u2083O\u2088 production <strong>993,843 lb</strong> (+33% QoQ), FY2025 total <strong>3.02M lb</strong>.  </li>\n<li><strong>Sales</strong>: Q4 sales <strong>710,051 lb</strong>, FY2025 total <strong>2.71M lb</strong> (includes <strong>365k lb loan material</strong>).  </li>\n<li><strong>Realized price</strong>: <strong>$55.6/lb</strong> (Q4), FY2025 avg. <strong>$65.7/lb</strong>; cost of production <strong>$40.2/lb</strong> (FY2025).  </li>\n<li><strong>Cash</strong>: <strong>$89.0M</strong> (excluding $4.4M restricted), undrawn <strong>$50M revolvinfacility</strong>. Drawn debt <strong>$86.5M</strong>.  </li>\n</ul>\n<h3><strong>Langer Heinrich Mine (LHM)</strong></h3>\n<ul>\n<li><strong>Record throughput</strong>: Crusher circuit <strong>1.17Mt</strong> (highest ever).  </li>\n<li><strong>Contracts</strong>: 13 sales agreements (57% market-linked, 43% fixed/escalated). <strong>24.1M lb</strong> contracted to 2030.  </li>\n<li><strong>FY2026 Guidance</strong>:  </li>\n<li>Production: <strong>4.0\u20134.4M lb</strong>.  </li>\n<li>Unit cost: <strong>$44\u201348/lb</strong>.  </li>\n<li>Capex: <strong>$26\u201332M</strong>.  </li>\n</ul>\n<h3><strong>Patterson Lake South (PLS) Project</strong></h3>\n<ul>\n<li><strong>Milestone</strong>: Final EIS accepted by Saskatchewan Ministry of Environment.  </li>\n<li><strong>Exploration</strong>: Significant radioactivity results at Saloon East (new zone of interest).  </li>\n</ul>\n<h3><strong>Key Risks/Market Context</strong></h3>\n<ul>\n<li>Uranium market: Long-term uncovered utility demand <strong>~1B lb</strong> (next decade).  </li>\n<li>Sensitivity: FY2026 realized price ranges <strong>$54\u201394/lb</strong> (spot $40\u2013140/lb).  </li>\n</ul>\n<h3><strong>Governance</strong></h3>\n<ul>\n<li>CEO appointment: <strong>Paul Hemburrow</strong> (effective 1 Sept 2025).  </li>\n</ul>\n<p>No material capital raising or trading halt information identified.  </p>\n<p><em>Focus: Strong operational ramp-up, favorable contract book, and exploration upside.</em></p>",
    "usage": {
      "prompt_tokens": 7483,
      "completion_tokens": 477,
      "total_tokens": 7960,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:50:53.029824"
  },
  {
    "ticker": "1CG",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971719",
    "id": "02971719",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0843",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1n46q49c8nn.pdf",
    "summary": "<p><strong>Summary of ASX Announcement \u2013 1CG Revenue Update (23 July 2025):</strong>  </p>\n<ul>\n<li><strong>Revenue Growth</strong>: July 2025 revenue (unaudited) exceeded full July 2024 revenue ($2.2M) within the first 18 days of July 2025.  </li>\n<li><strong>Customer Retention</strong>: Returning customer lodgement rate improved to 72% (vs. 63% prior year).  </li>\n<li><strong>Market Outperformance</strong>: Achieved despite ATO reporting a 10% YoY decline in overall tax lodgements.  </li>\n</ul>\n<p><em>Note: No capital markets or trading-sensitive actions (e.g., raise, halt, guidance change) identified.</em></p>",
    "usage": {
      "prompt_tokens": 926,
      "completion_tokens": 139,
      "total_tokens": 1065,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:53:02.210767"
  },
  {
    "ticker": "LNQ",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971718",
    "id": "02971718",
    "pages": 26,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0843",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1n21w9l9d00.pdf",
    "summary": "<h3><strong>LinQ Minerals Limited (ASX: LNQ) - Material Information Summary</strong></h3>\n<h4><strong>Key Corporate Details</strong></h4>\n<ul>\n<li><strong>Shares on Issue:</strong> 175.8m  </li>\n<li><strong>Market Cap (22 July 2025):</strong> A$26.4m (at 15c/share)  </li>\n<li><strong>Cash Balance (30 June 2025):</strong> ~A$9.7m  </li>\n<li><strong>Substantial Shareholders:</strong> Woodcross Holdings (48.67%), Michael Gibson (11.70%), Sam Investors (11.57%)  </li>\n<li><strong>Unlisted Options:</strong> 18.2m (exercise prices: A$0.20\u2013A$0.30)  </li>\n</ul>\n<h4><strong>Gilmore Project Highlights</strong></h4>\n<ul>\n<li><strong>JORC Resource (Global):</strong>  </li>\n<li>516Mt @ 0.4% CuEq (~3.7Moz Au, ~1.2Mt Cu)  </li>\n<li><strong>Gilmore South (Brownfield Gold-Copper Project):</strong>  </li>\n<li>55Mt @ 1.00g/t Au, 0.07% Cu (Gidginbung) + 34Mt @ 0.7% CuEq (Dam)  </li>\n<li>Historical production (1996) at ~A$460/oz Au; resources open at depth/strike.  </li>\n<li><strong>Exploration Upside:</strong>  </li>\n<li>+16,000m drilling program commencing July 2025 (Gidginbung focus).  </li>\n<li>Targets: Epithermal Au (e.g., 25m @ 8.90g/t Au at Fields) and Cu-Au porphyries (e.g., 150m @ 1.6% CuEq at Monza).  </li>\n</ul>\n<h4><strong>Catalysts &amp; Timetable</strong></h4>\n<ul>\n<li><strong>Q3\u2013Q4 2025:</strong> Drilling at Gidginbung, Dam, and Central Zone targets.  </li>\n<li><strong>Infrastructure:</strong> Adjacent to road/rail/water/power (NSW location).  </li>\n</ul>\n<h4><strong>Valuation Drivers</strong></h4>\n<ul>\n<li>Leverage to Au/Cu prices; potential resource growth.  </li>\n<li>Tight capital structure (Board/management own &gt;60%).  </li>\n</ul>\n<p><strong>No capital raising or material financial changes announced.</strong>  </p>\n<p><em>(Note: This is a presentation\u2014monitor ASX for formal announcements.)</em></p>",
    "usage": {
      "prompt_tokens": 12958,
      "completion_tokens": 477,
      "total_tokens": 13435,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:51:54.772317"
  },
  {
    "ticker": "AGE",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971714",
    "id": "02971714",
    "pages": 19,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0842",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1msq3d8vp6h.pdf",
    "summary": "<h3><strong>Material Information Summary \u2013 Alligator Energy (ASX: AGE)</strong></h3>\n<p><strong>Quarterly Report (30 June 2025)</strong>  </p>\n<h4><strong>Key Highlights:</strong></h4>\n<p><strong>Samphire Uranium Project:</strong><br />\n- <strong>MRE Update</strong>: Indicated resource increased by <strong>10% to 14.2 Mlbs U\u2083O\u2088</strong> (786 ppm); total resource up <strong>3% to 18.0 Mlbs U\u2083O\u2088</strong> (676 ppm).<br />\n- <strong>Regulatory Progress</strong>: Works Approval License received for Field Recovery Trial (FRT); PEPR approval pending (final step for construction).  </p>\n<p><strong>Corporate &amp; Financial:</strong><br />\n- <strong>Cash Balance</strong>: <strong>$30.1M</strong> (includes proceeds from placement).<br />\n- <strong>Capital Raising</strong>: <strong>$17.25M</strong> raised via placement (556M shares @ $0.031; includes 1-for-2 options exercisable at $0.047).<br />\n- <strong>Leadership Change</strong>: Andrea Marsland-Smith appointed CEO (effective 1 July 2025); Greg Hall transitions to Executive Director.  </p>\n<p><strong>Uranium Market:</strong><br />\n- <strong>Spot Price</strong>: Ended quarter at <strong>US$78.50/lb</strong> (up from US$64/lb in March 2025 but since drifted lower).<br />\n- <strong>Catalysts</strong>:<br />\n  - US policy shifts under Trump (streamlined nuclear approvals).<br />\n  - China approved 10 new reactors (30 under construction; target: 200 GW by 2040).<br />\n  - World Bank lifted nuclear funding ban.  </p>\n<p><strong>Operations:</strong><br />\n- <strong>Big Lake Project</strong>: Drilling delayed due to Cooper Basin floods; revised program planned for Q4 2025.<br />\n- <strong>Piedmont Project</strong>: Licenses relinquished due to lack of market interest.  </p>\n<p><strong>Appendix 4C (Cash Flow):</strong><br />\n- <strong>Net Operating Cash Outflow</strong>: <strong>($0.55M)</strong> for quarter.<br />\n- <strong>Exploration Spend</strong>: <strong>$1.97M</strong> (Samphire-focused).  </p>\n<p><strong>Forward Plans:</strong><br />\n- <strong>Samphire</strong>: Finalize PEPR approval, commence FRT construction tender.<br />\n- <strong>Big Lake</strong>: Resume drilling post-flood (Q4 2025).  </p>\n<hr />\n<p><strong>Note</strong>: Omitted routine operational updates and non-material details. Focused on impacts to valuation, liquidity, and capital structure.</p>",
    "usage": {
      "prompt_tokens": 10552,
      "completion_tokens": 490,
      "total_tokens": 11042,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:49:14.323266"
  },
  {
    "ticker": "PDN",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971712",
    "id": "02971712",
    "pages": 6,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0842",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1mnkjxq2twq.pdf",
    "summary": "<h3><strong>Paladin Energy Ltd \u2013 Appendix 5B Quarterly Cash Flow Report Summary (30 June 2025)</strong></h3>\n<h4><strong>Key Financial Highlights</strong></h4>\n<ul>\n<li><strong>Cash &amp; Cash Equivalents (EOQ):</strong> <strong>US$89.0M</strong> (down from US$117.3M last quarter).  </li>\n<li><strong>Net Cash Used in Operations:</strong> <strong>US$(18.4M)</strong> (primarily due to production costs of US$47.5M and corporate expenses).  </li>\n<li><strong>Investing Activities:</strong> Net cash outflow of <strong>US$(5.8M)</strong> (exploration spend: US$10.0M; PPE: US$6.6M).  </li>\n<li><strong>Financing Activities:</strong> Net outflow of <strong>US$(6.8M)</strong> (loan repayments: US$6.8M).  </li>\n</ul>\n<h4><strong>Capital Structure &amp; Liquidity</strong></h4>\n<ul>\n<li><strong>Total Debt Facilities:</strong> <strong>US$219.4M</strong> (US$169.3M drawn).  </li>\n<li><strong>Secured Term Loan (Nedbank/Macquarie):</strong>  <ul>\n<li>US$100M term loan (5-year maturity, amortising).  </li>\n<li>US$50M revolving facility (3-year maturity).  </li>\n</ul>\n</li>\n<li><strong>CNOL Shareholder Loans (Unsecured):</strong> US$82.8M drawn (varied maturity dates, interest terms).  </li>\n<li><strong>Available Liquidity:</strong> <strong>US$139.1M</strong> (cash + undrawn facilities).  </li>\n</ul>\n<h4><strong>Material Notes</strong></h4>\n<ul>\n<li><strong>Langer Heinrich Restart Costs:</strong> US$0.4M spent in quarter (US$3.6M YTD).  </li>\n<li><strong>Related-Party Payments:</strong> US$233K (directors\u2019 fees).  </li>\n</ul>\n<h4><strong>Trading Implications</strong></h4>\n<ul>\n<li><strong>No immediate funding risk</strong> (positive liquidity buffer).  </li>\n<li><strong>Continued cash burn in operations</strong> (monitor production cost trends).  </li>\n</ul>\n<p><strong>No material capital-raising or corporate action announced.</strong>  </p>\n<hr />\n<p><em>Note: FX rates critical for AUD conversion (report in USD).</em></p>",
    "usage": {
      "prompt_tokens": 3885,
      "completion_tokens": 421,
      "total_tokens": 4306,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:51:35.266515"
  },
  {
    "ticker": "AGN",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971713",
    "id": "02971713",
    "pages": 10,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0842",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1mqm97m56my.pdf",
    "summary": "<h3><strong>Appendix 4C Quarterly Report Summary (Argenica Therapeutics \u2013 AGN)</strong></h3>\n<h4><strong>Key Operational/Financial Highlights:</strong></h4>\n<ul>\n<li><strong>Phase 2 Trial Completion:</strong> Final patient dosed in April 2025 for ARG-007 in acute ischemic stroke (AIS). Topline data expected <strong>Q3 2025</strong>. Primary endpoints focus on safety; secondary on infarct volume reduction.  </li>\n<li><strong>Preclinical TBI Data:</strong> Positive results in ferret model for moderate traumatic brain injury (modTBI), supporting clinical development.  </li>\n<li><strong>Regulatory:</strong> FDA placed <strong>clinical hold</strong> on US IND application for AIS (non-clinical data deemed insufficient). No impact on ongoing Australian Phase 2 trial.  </li>\n<li><strong>Funding:</strong>  </li>\n<li><strong>$1.5m non-dilutive grant</strong> awarded (MRFF) for future stroke trials ($1m initial tranche received post-quarter).  </li>\n<li><strong>$10.5m cash balance</strong> (30 June 2025) covers Phase 2 completion.  </li>\n<li><strong>R&amp;D Tax Incentive</strong> expected in Q4 2025.  </li>\n</ul>\n<h4><strong>Cash Flow (Quarter Ended 30 June 2025):</strong></h4>\n<ul>\n<li><strong>Net operating outflow:</strong> <strong>$2.36m</strong> (R&amp;D: $2.1m, staff: $0.4m).  </li>\n<li><strong>Cash runway:</strong> ~4.5 quarters at current burn rate.  </li>\n</ul>\n<hr />\n<p><strong>Brevity Note:</strong> Excluded routine updates (e.g., patent grants, advisory committee formation) as non-material to immediate trading. Focused on catalysts (Phase 2 data, FDA hold), liquidity, and funding.</p>",
    "usage": {
      "prompt_tokens": 6270,
      "completion_tokens": 343,
      "total_tokens": 6613,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:52:49.777917"
  },
  {
    "ticker": "ALL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971716",
    "id": "02971716",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0842",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1mxv2jvt6h3.pdf",
    "summary": "<p><strong>Summary of ASX Announcement (Appendix 3C - Buy-back Notification):</strong>  </p>\n<ul>\n<li><strong>Type of Buy-back:</strong> On-market buy-back.  </li>\n<li><strong>Total Buy-back Program:</strong> Up to <strong>$750 million</strong> of ordinary shares (ALL).  </li>\n<li><strong>Daily Buy-back Activity (22/7/2025):</strong>  </li>\n<li><strong>Shares Bought:</strong> 86,044.  </li>\n<li><strong>Total Bought to Date:</strong> 3,300,695.  </li>\n<li><strong>Daily Consideration:</strong> AUD 5.80 million (avg. ~AUD 67.40/share).  </li>\n<li><strong>Price Range (Previous Day):</strong> AUD 67.05 (low) to AUD 67.80 (high).  </li>\n<li><strong>Program Period:</strong> 7/3/2025 to 6/3/2026.</li>\n</ul>",
    "usage": {
      "prompt_tokens": 1519,
      "completion_tokens": 174,
      "total_tokens": 1693,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:53:23.746170"
  },
  {
    "ticker": "REY",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971709",
    "id": "02971709",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0841",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1mg7hl2x45m.pdf",
    "summary": "<ul>\n<li><strong>Substantial Holder Change</strong>: Vigorous Resources Pty Ltd increased its voting power in Rey Resources Limited from 53.047% to 71.722%.  </li>\n<li><strong>Transaction Details</strong>:  </li>\n<li><strong>21/7/2025</strong>: Acquired 1,265,507 ordinary shares at $35,434.20 (off-market takeover).  </li>\n<li><strong>22/7/2025</strong>: Acquired 38,243,355 ordinary shares at $1,070,813.94 (off-market takeover).  </li>\n<li><strong>Current Holdings</strong>: Vigorous holds 151,734,743 ordinary shares (71.722% voting power).  </li>\n</ul>\n<p><em>No other material information identified.</em></p>",
    "usage": {
      "prompt_tokens": 1565,
      "completion_tokens": 141,
      "total_tokens": 1706,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:52:56.571081"
  },
  {
    "ticker": "FPR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971710",
    "id": "02971710",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0841",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1mj97t98f4g.pdf",
    "summary": "<ul>\n<li><strong>Buy-back type</strong>: On-market buy-back  </li>\n<li><strong>Total shares bought back as of previous day</strong>: 80,079,031 (+90,500 on 22/7/2025)  </li>\n<li><strong>Total consideration paid</strong>: AUD 212,952,383 (AUD 280,459 on 22/7/2025)  </li>\n<li><strong>Price range</strong>: AUD 1.87 (low) to AUD 3.69 (high)  </li>\n<li><strong>Buy-back period</strong>: 10/5/2023 to 23/1/2026  </li>\n<li><strong>Maximum shares approved for buy-back</strong>: 25 million (post-AGM 23/1/2025)  </li>\n<li><strong>Broker executing buy-back</strong>: Morgan Stanley Australia Securities Limited  </li>\n<li><strong>No shareholder approval required</strong>.  </li>\n</ul>\n<p><em>Omitted: Routine daily price/volume details, legal boilerplate.</em></p>",
    "usage": {
      "prompt_tokens": 1547,
      "completion_tokens": 181,
      "total_tokens": 1728,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:53:57.492661"
  },
  {
    "ticker": "AKN",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971708",
    "id": "02971708",
    "pages": 21,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0841",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1md3nstr8ty.pdf",
    "summary": "<p>No material information identified.  </p>\n<p>(The announcement is a routine conference presentation with no new material disclosures affecting trading, capital structure, or valuation.)</p>",
    "usage": {
      "prompt_tokens": 4071,
      "completion_tokens": 28,
      "total_tokens": 4099,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:51:58.758424"
  },
  {
    "ticker": "TLX",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971707",
    "id": "02971707",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0840",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1m9vys9trbt.pdf",
    "summary": "<ul>\n<li><strong>Escrow Release</strong>: 47,256 ordinary shares (issued to Lightpoint Medical Limited as acquisition consideration) will be released from voluntary escrow on <strong>31 July 2025</strong>.</li>\n</ul>",
    "usage": {
      "prompt_tokens": 1612,
      "completion_tokens": 39,
      "total_tokens": 1651,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:52:11.418845"
  },
  {
    "ticker": "QML",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971706",
    "id": "02971706",
    "pages": 20,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0839",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1m7kqmm1sll.pdf",
    "summary": "<p><strong>No material information identified</strong>  </p>\n<ul>\n<li>Document appears to be a strategy/presentation deck without specific actionable or time-sensitive updates.  </li>\n<li>Contains historical exploration data and generic forward-looking statements with no new material disclosures.  </li>\n<li>Highlights existing resource/reserve estimates and growth strategy, but no new capital markets or trading-relevant details.  </li>\n</ul>\n<p><em>Note: Mainly promotional content with no concrete announcements (e.g., no capital raising, trading halt, or operational milestones requiring immediate attention).</em></p>",
    "usage": {
      "prompt_tokens": 4256,
      "completion_tokens": 97,
      "total_tokens": 4353,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:49:42.561875"
  },
  {
    "ticker": "QPM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971705",
    "id": "02971705",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0836",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1m4xlc99fxh.pdf",
    "summary": "<p><strong>Capital Raising Announcement Summary:</strong><br />\n- <strong>Structure:</strong> Share Purchase Plan (SPP) upsized due to strong demand.<br />\n- <strong>Total raised:</strong> ~$7.0 million (originally $2.0 million target).<br />\n- <strong>Key dates:</strong> Shares issued on <strong>24 July 2025</strong>, trading commences <strong>25 July 2025</strong>.<br />\n- <strong>Use of proceeds:</strong> Accelerate Isaac Power Station (IPS) development (engineering, grid connection), technical reports for debt financing, and gas supply initiatives.<br />\n- <strong>Pricing:</strong> Shares issued at <strong>$0.031</strong> each (~226.1 million shares).  </p>\n<p><em>(Omitted CEO commentary, forward-looking statements, and administrative details as non-material.)</em></p>",
    "usage": {
      "prompt_tokens": 1088,
      "completion_tokens": 150,
      "total_tokens": 1238,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:51:20.985209"
  },
  {
    "ticker": "BGD",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971703",
    "id": "02971703",
    "pages": 20,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0834",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1m0dstywhgz.pdf",
    "summary": "<p>No material information identified.  </p>\n<p>(Note: The provided document appears to be a corporate presentation with general updates on projects, resources, and strategic plans, but it does not contain explicit material announcements such as capital raisings, trading halts, or financial results requiring immediate trading or capital markets action.)</p>",
    "usage": {
      "prompt_tokens": 9062,
      "completion_tokens": 61,
      "total_tokens": 9123,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:48:53.804125"
  },
  {
    "ticker": "ATA",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971701",
    "id": "02971701",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0832",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1lvrj6srxdv.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type</strong>: On-market  </li>\n<li><strong>Total Shares Bought Back to Date</strong>: 3,557,054 (3,257,054 prior + 300,000 on 22/7/2025)  </li>\n<li><strong>Maximum Buy-back Target</strong>: 31,000,000 (remaining: 27,442,946)  </li>\n<li><strong>Buy-back Period</strong>: 29/4/2025 to 9/4/2026  </li>\n<li><strong>Daily Buy-back Details (22/7/2025)</strong>:  </li>\n<li>Quantity: 300,000 shares  </li>\n<li>Total Consideration: AUD 254,400  </li>\n<li>Price Range: AUD 0.84000 (low) to AUD 0.85000 (high)  </li>\n<li><strong>Highest Price Allowed (ASX Rule 7.33)</strong>: AUD 0.86840  </li>\n</ul>\n<p><em>No material impact on capital structure (no shareholder approval required).</em></p>",
    "usage": {
      "prompt_tokens": 1497,
      "completion_tokens": 194,
      "total_tokens": 1691,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:53:09.275858"
  },
  {
    "ticker": "QPM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971702",
    "id": "02971702",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0832",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1lxwybvpbxr.pdf",
    "summary": "<ul>\n<li><strong>Operational Update</strong>: Townsville Power Station (TPS) gas turbine successfully commenced electricity dispatch to NEM on 21 July 2025 but encountered a trip event during ramp-up.  </li>\n<li><strong>Issue Resolution</strong>: Cause of the trip identified; commissioning expected to resume later in the week, with operations anticipated to restart shortly.  </li>\n</ul>\n<p><em>No material financial or capital markets impact identified.</em></p>",
    "usage": {
      "prompt_tokens": 702,
      "completion_tokens": 78,
      "total_tokens": 780,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:50:08.526545"
  },
  {
    "ticker": "GBR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971700",
    "id": "02971700",
    "pages": 19,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0831",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1lsmp2nk0qp.pdf",
    "summary": "<ul>\n<li><strong>Key Project Highlights</strong>:  </li>\n<li>Side Well Gold Project resource: <strong>668koz @ 2.8g/t Au</strong> (incl. high-grade core of <strong>496koz @ 5.3g/t</strong>).  </li>\n<li>Exploration Target: <strong>940koz\u20131.1Moz</strong> with significant upside.  </li>\n<li>\n<p><strong>Ironbark Deposit Scoping Study</strong>:  </p>\n<ul>\n<li>Production Target: <strong>79koz Au</strong> (1.26Mt @ 2.0g/t).  </li>\n<li>NPV (A$5,064/oz): <strong>A$137M</strong>; IRR: <strong>152%</strong>.  </li>\n<li>Low capex: <strong>A$3.1M</strong> (toll-treatment assumption).  </li>\n</ul>\n</li>\n<li>\n<p><strong>Strategic Positioning</strong>:  </p>\n</li>\n<li>\n<p>Located near processing hubs:  </p>\n<ul>\n<li><strong>25km</strong> from Westgold\u2019s Bluebird mill (1.8Mtpa).  </li>\n<li><strong>40km</strong> to Meeka Metals\u2019 Andy Well mill (0.7Mtpa).  </li>\n</ul>\n</li>\n<li>\n<p><strong>Recent Drill Results (High-Grade)</strong>:  </p>\n</li>\n<li><strong>Mulga Bill</strong>: 6m @ <strong>589.44g/t Au</strong>, 14m @ <strong>36.12g/t Au</strong>.  </li>\n<li><strong>Ironbark</strong>: 5m @ <strong>51.65g/t Au</strong>, 12m @ <strong>10.24g/t Au</strong>.  </li>\n<li>\n<p><strong>Saltbush</strong>: 10m @ <strong>6.47g/t Au</strong>, 9m @ <strong>5.2g/t Au</strong>.  </p>\n</li>\n<li>\n<p><strong>Project Development</strong>:  </p>\n</li>\n<li>Mining lease application lodged for Ironbark.  </li>\n<li>\n<p>Metallurgical tests completed (Mulga Bill: high recovery rates).  </p>\n</li>\n<li>\n<p><strong>Corporate</strong>:  </p>\n</li>\n<li><strong>Market Cap</strong>: ~A$59M (965.7M shares @ A$0.061).  </li>\n<li><strong>Cash</strong>: A$15M; <strong>Debt</strong>: Nil.  </li>\n<li>\n<p>General meeting for placement approval: <strong>13 August 2025</strong>.  </p>\n</li>\n<li>\n<p><strong>Material Catalyst</strong>: Ironbark\u2019s NPV (<strong>A$137M</strong>) exceeds current enterprise value.  </p>\n</li>\n</ul>\n<p><em>No capital raising or material operational disruptions announced.</em></p>",
    "usage": {
      "prompt_tokens": 5103,
      "completion_tokens": 447,
      "total_tokens": 5550,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:53:46.925512"
  },
  {
    "ticker": "NYR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971699",
    "id": "02971699",
    "pages": 5,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0830",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1lq98lg5d3z.pdf",
    "summary": "<p><strong>Key Material Information from Nyrada Inc. Announcement (23 July 2025):</strong>  </p>\n<ul>\n<li><strong>Clinical Trial Progress</strong>:  </li>\n<li>Phase IIa trial for <strong>Xolatryp\u2122</strong> targeting <strong>acute myocardial infarction (AMI)</strong> planned, focusing on <strong>STEMI patients undergoing PCI</strong>.  </li>\n<li><strong>Indicative design</strong>: 150 patients, randomized, double-blind, placebo-controlled, testing two doses via 6-hour infusion.  </li>\n<li>\n<p><strong>Targeted start</strong>: Q1 2026 (pending Phase I completion and HREC approval).  </p>\n</li>\n<li>\n<p><strong>Phase I Status</strong>:  </p>\n</li>\n<li>\n<p>Final cohort dosed with <strong>no adverse safety signals</strong>; final data expected <strong>September 2025 quarter</strong>.  </p>\n</li>\n<li>\n<p><strong>Strategic Focus</strong>:  </p>\n</li>\n<li>\n<p>Priority shift to <strong>cardioprotection</strong> due to strong preclinical data and funding limitations for TBI/stroke programs.  </p>\n</li>\n<li>\n<p><strong>Market Opportunity</strong>:  </p>\n</li>\n<li>\n<p><strong>$11.7B global PCI market (2024)</strong>, growing at <strong>10.03% CAGR</strong>; ~950,000 PCIs annually in the US.  </p>\n</li>\n<li>\n<p><strong>Preclinical Efficacy</strong>:  </p>\n</li>\n<li><strong>86% cardioprotection</strong> (6-hour treatment) and <strong>42% efficacy</strong> (3-hour treatment) in infarct models.  </li>\n<li>Neuroprotection data in stroke/TBI (statistically significant results).  </li>\n</ul>\n<p><strong>No capital raising, trading halt, or financial data disclosed.</strong></p>",
    "usage": {
      "prompt_tokens": 2730,
      "completion_tokens": 290,
      "total_tokens": 3020,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:51:09.865783"
  },
  {
    "ticker": "ALD",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971698",
    "id": "02971698",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0830",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1ln49q62h0q.pdf",
    "summary": "<h3><strong>Trading Update Summary (1H 2025)</strong></h3>\n<h4><strong>Financial Highlights</strong></h4>\n<ul>\n<li><strong>Unaudited 1H 2025 RCOP EBITDA:</strong> <strong>~$640m</strong>  </li>\n<li><strong>Unaudited 1H 2025 RCOP EBIT:</strong> <strong>~$400m</strong>  </li>\n<li><strong>Lytton Refiner Margin (1H 2025):</strong> <strong>US$7.44/bbl</strong> (down <strong>28% YoY</strong>)  </li>\n<li><strong>2Q 2025 LRM:</strong> <strong>US$8.71/bbl</strong> (vs. <strong>US$8.81/bbl</strong> in 2Q 2024)  </li>\n</ul>\n<h4><strong>Segment Performance</strong></h4>\n<ul>\n<li><strong>Convenience Retail &amp; NZ:</strong> EBIT growth (driven by premium fuel mix &amp; diversified channels).  </li>\n<li><strong>Fuels &amp; Infrastructure (Australia):</strong> Flat EBIT (middle distillate margin improvements offset supply chain impacts).  </li>\n<li><strong>Lytton Refinery:</strong> ~Breakeven EBIT (profitable 2Q due to higher LRM).  </li>\n</ul>\n<h4><strong>Key Volume Trends (1H 2025 vs. 1H 2024)</strong></h4>\n<ul>\n<li><strong>Group sales volumes:</strong> <strong>12,448 ML</strong> (\u2193 <strong>6.1%</strong> YoY)  </li>\n<li>Australia wholesale: <strong>5,611 ML</strong> (\u2193 <strong>1.2%</strong>)  </li>\n<li>International (ex-NZ): <strong>3,238 ML</strong> (\u2193 <strong>17.5%</strong>)  </li>\n<li>NZ: <strong>1,864 ML</strong> (\u2191 <strong>1.9%</strong>)  </li>\n</ul>\n<h4><strong>Forward Updates</strong></h4>\n<ul>\n<li><strong>Full 1H audited results:</strong> Due <strong>18 August 2025</strong>.  </li>\n</ul>\n<h3><strong>Material Takeaways</strong></h3>\n<ol>\n<li><strong>Profit resilience</strong> despite volume declines, supported by retail/NZ growth and refining margins.  </li>\n<li><strong>Weaker international volumes</strong> (ex-NZ) and <strong>lower LRM</strong> (vs. prior year) key drags.  </li>\n<li>No <strong>Fuel Security Services Payment</strong> expected for 2Q 2025.  </li>\n</ol>\n<p><em>Omitted: Operational minutiae, forward guidance details, non-material segment commentary.</em></p>",
    "usage": {
      "prompt_tokens": 1717,
      "completion_tokens": 447,
      "total_tokens": 2164,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:52:34.543385"
  },
  {
    "ticker": "RAC",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971697",
    "id": "02971697",
    "pages": 9,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0828",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1lkvkgrhfpk.pdf",
    "summary": "<h3><strong>Race Oncology Ltd \u2013 ASX Announcement Summary (Quarterly Report \u2013 Appendix 4C)</strong></h3>\n<h4><strong>Material Information for Trading/Capital Markets Decisions</strong></h4>\n<ul>\n<li><strong>Clinical Milestones</strong>:  </li>\n<li>First patient dosed with <strong>RC220 alone</strong> and <strong>RC220 + doxorubicin</strong> in Phase 1 trial for advanced solid tumours (no adverse events reported).  </li>\n<li>\n<p>Post-quarter: Ethics approval received for Phase 1 trial at <strong>Prince of Wales and Queen Mary Hospitals (Hong Kong)</strong>.  </p>\n</li>\n<li>\n<p><strong>Leadership Changes</strong>:  </p>\n</li>\n<li>\n<p>Appointment of <strong>Dr. Jose Iglesias (CMO)</strong> and <strong>Dr. Simon Fisher (VP of Medical)</strong>.  </p>\n</li>\n<li>\n<p><strong>Cash Position</strong>:  </p>\n</li>\n<li><strong>Closing cash balance: $13.67m</strong> (sufficient to fund operations through CY2026).  </li>\n<li>\n<p>Quarterly R&amp;D spend: <strong>$3.11m</strong> (83% of total expenses).  </p>\n</li>\n<li>\n<p><strong>IP Update</strong>:  </p>\n</li>\n<li>\n<p>Termination of <strong>City of Hope license agreement</strong> (deemed no longer valuable; retains full freedom to operate with bisantrene).  </p>\n</li>\n<li>\n<p><strong>Shareholder Structure</strong>:  </p>\n</li>\n<li><strong>Top 20 holders control 33.54%</strong>. Largest holder: <strong>CEO Dr. Daniel Tillett (10.13%)</strong>.  </li>\n</ul>\n<h4><strong>Excluded (Non-Material)</strong></h4>\n<ul>\n<li>Routine investor presentations (Gold Coast Showcase, ESMO 2025 selection).  </li>\n<li>Minor option conversions ($28k raised).  </li>\n<li>Director fee disclosures.  </li>\n</ul>\n<p><strong>Format:</strong> Consistent with Appendix 4C requirements; extracted only material operational/financial data impacting valuation or liquidity.  </p>\n<p><em>No capital raising, trading halt, or other material corporate actions identified.</em></p>",
    "usage": {
      "prompt_tokens": 5728,
      "completion_tokens": 352,
      "total_tokens": 6080,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:50:43.241069"
  },
  {
    "ticker": "DXS",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971696",
    "id": "02971696",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0827",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1lhlc92gr48.pdf",
    "summary": "<h3>Key Material Information:</h3>\n<ul>\n<li><strong>Strategic Investment in Retail Asset:</strong>  </li>\n<li>Dexus Wholesale Shopping Centre Fund (DWSF) acquires <strong>25% stake in Westfield Chermside (Brisbane) for $683M</strong> (excl. costs).  </li>\n<li>\n<p>Dexus <strong>co-invests additional $170M</strong> in DWSF, taking total investment to <strong>$300M</strong>.  </p>\n</li>\n<li>\n<p><strong>Divestment Program Updates:</strong>  </p>\n</li>\n<li>Sold <strong>116-130 Gilmore Road (industrial) for $32M</strong> (6.7% above book value).  </li>\n<li>Sold <strong>149 Orchard Road (50% stake) for $121.5M</strong>, expecting <strong>~$9M pre-tax trading profit in FY26</strong>.  </li>\n<li>Total divestment proceeds: <strong>$153.5M</strong> (Dexus share: <strong>$92.8M</strong>).  </li>\n</ul>\n<h3>Omitted: Non-material details (management commentary, property descriptions, operational updates).</h3>",
    "usage": {
      "prompt_tokens": 1411,
      "completion_tokens": 207,
      "total_tokens": 1618,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:49:22.761165"
  },
  {
    "ticker": "OSL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971694",
    "id": "02971694",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0827",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1lcf929cn3b.pdf",
    "summary": "<ul>\n<li><strong>Completion of patient recruitment for TRIPP-FFX clinical trial</strong> (target: 88 patients across 15 hospitals).  </li>\n<li><strong>Expected data readout in early 2026</strong>\u2014evaluating safety/efficacy of OncoSil\u2122 device combined with FOLFIRINOX chemotherapy for pancreatic cancer.  </li>\n<li><strong>Milestone for clinical strategy</strong>, supporting broader adoption of the device.  </li>\n</ul>\n<p><em>No material financial, capital, or trading-specific information identified.</em></p>",
    "usage": {
      "prompt_tokens": 1637,
      "completion_tokens": 95,
      "total_tokens": 1732,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:35:08.820761"
  },
  {
    "ticker": "WBC",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971695",
    "id": "02971695",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0827",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1lfj2svfss9.pdf",
    "summary": "<h3>Summary of ASX Announcement (Appendix 3C - Buy-back Notification):</h3>\n<ul>\n<li><strong>Type of Buy-back</strong>: On-market buy-back  </li>\n<li><strong>Total Shares Bought Back (Cumulative)</strong>: 87,622,014  </li>\n<li><strong>Shares Bought Back (Previous Day)</strong>: 606,926  </li>\n<li><strong>Total Consideration (Cumulative)</strong>: AUD 2,448,458,449.79  </li>\n<li><strong>Consideration (Previous Day)</strong>: AUD 19,813,896.72  </li>\n<li><strong>Current Buy-back Program</strong>: Up to <strong>AUD 3.5 billion</strong> of ordinary shares, running until <strong>11 November 2025</strong>.  </li>\n<li><strong>Highest Price Paid (Previous Day)</strong>: AUD 33.21  </li>\n<li><strong>Lowest Price Paid (Program)</strong>: AUD 21.49 (on 6/12/2023).  </li>\n</ul>\n<p><em>No other material information identified.</em></p>",
    "usage": {
      "prompt_tokens": 1545,
      "completion_tokens": 190,
      "total_tokens": 1735,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:38:29.519503"
  },
  {
    "ticker": "SVM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971693",
    "id": "02971693",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0826",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1l9532k1bcm.pdf",
    "summary": "<h3>Summary of Material Information:</h3>\n<ul>\n<li><strong>DFS Progress Update</strong>:  </li>\n<li>Completion of extensive geotechnical investigations for <strong>Kasiya Rutile Graphite Project</strong> (DFS stage).  </li>\n<li>Over <strong>400 tests</strong> conducted across critical infrastructure (mining, TSF, raw water dam).  </li>\n<li><strong>Preliminary findings</strong>: Confirmed favourable subsurface conditions, consistent stratigraphy, and potential cost savings via standardised designs.  </li>\n<li><strong>Next steps</strong>: Data to support detailed engineering and de-risk infrastructure planning in DFS.  </li>\n</ul>\n<p><em>No material trading or capital markets impact identified (operational update only).</em></p>",
    "usage": {
      "prompt_tokens": 2295,
      "completion_tokens": 126,
      "total_tokens": 2421,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:36:56.340639"
  },
  {
    "ticker": "WGX",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971692",
    "id": "02971692",
    "pages": 33,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0825",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1l6wjc94vxw.pdf",
    "summary": "<p>Here\u2019s the concise extraction of material information from the Westgold Resources Q4 FY25 Quarterly Results announcement:</p>\n<h3><strong>Operational Highlights:</strong></h3>\n<ul>\n<li><strong>Production</strong>:  </li>\n<li>Q4 FY25: <strong>88,022oz</strong> produced at <strong>AISC of A$2,688/oz</strong>.  </li>\n<li>FY25 total: <strong>326,384oz</strong> (vs. guidance: 330,000\u2013350,000oz).  </li>\n<li><strong>Sales</strong>: <strong>71,500oz</strong> sold at <strong>A$5,174/oz</strong>, generating <strong>A$370M revenue</strong>.  </li>\n<li><strong>Margin</strong>: <strong>AISC margin of A$2,486/oz</strong> (achieved gold price above AISC).  </li>\n</ul>\n<h3><strong>Financial Highlights:</strong></h3>\n<ul>\n<li><strong>Cash Position</strong>: <strong>A$364M</strong> in closing cash, bullion, and liquid investments (<strong>+A$132M QoQ</strong>).  </li>\n<li><strong>Debt Facility</strong>: <strong>A$250M corporate facility</strong> unused; total liquidity <strong>~A$614M</strong>.  </li>\n<li><strong>Synergies</strong>: <strong>A$54M annual savings achieved</strong> (exceeding A$49M target).  </li>\n</ul>\n<h3><strong>Growth &amp; Development:</strong></h3>\n<ul>\n<li><strong>Beta Hunt</strong>: Expansion to <strong>&gt;2Mtpa</strong> (infrastructure upgrades underway).  </li>\n<li><strong>Fletcher Zone</strong>: Maiden <strong>Stage 1 Resource of 2.3Moz</strong> (open at depth).  </li>\n<li><strong>Bluebird-South Junction</strong>: Targeting <strong>1.2Mtpa</strong> mining rate by late FY26.  </li>\n</ul>\n<h3><strong>Key Risks/Missed Targets:</strong></h3>\n<ul>\n<li><strong>FY25 Guidance Miss</strong>: Production (326,384oz) and AISC (A$2,666/oz) slightly below guidance ranges.  </li>\n</ul>\n<h3><strong>Forward Focus:</strong></h3>\n<ul>\n<li><strong>Murchison</strong>: Optimize grade and margins at Big Bell/Bluebird.  </li>\n<li><strong>Southern Goldfields</strong>: Beta Hunt expansion and Fletcher Zone Reserve conversion.  </li>\n</ul>\n<p><strong>No capital raising, trading halt, or other material corporate actions identified.</strong>  </p>\n<p><em>(Note: Omitted operational minutiae, safety stats, and non-impactful reserves/resources tables.)</em></p>",
    "usage": {
      "prompt_tokens": 12610,
      "completion_tokens": 435,
      "total_tokens": 13045,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:35:31.649000"
  },
  {
    "ticker": "GAL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971691",
    "id": "02971691",
    "pages": 7,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0824",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1l4mpwj1fk0.pdf",
    "summary": "<ul>\n<li><strong>Drill Program Commenced</strong>: 5,000m aircore drilling targeting Platinum Group Elements (PGEs) at Norseman project, Western Australia.  </li>\n<li><strong>Key Targets</strong>: Follow-up on high-grade intercepts (e.g., 4.1 g/t Pd, 2.5 g/t Pt over 1m) and anomalous zones (e.g., 4m @ 1.12 g/t 3E).  </li>\n<li><strong>Existing Resource</strong>: Norseman hosts JORC resource of 1.27Moz PdEq (Callisto deposit).  </li>\n<li><strong>Timing</strong>: Drilling to complete in 3 weeks; assay results expected 4 weeks post-drilling.  </li>\n<li><strong>Exploration Potential</strong>: Aim to expand resource in underexplored 270km\u00b2 tenement.  </li>\n</ul>\n<p>No capital raising, financials, or material corporate actions disclosed. Focus is on operational progress.</p>",
    "usage": {
      "prompt_tokens": 2708,
      "completion_tokens": 191,
      "total_tokens": 2899,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:41:01.104593"
  },
  {
    "ticker": "WGX",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971689",
    "id": "02971689",
    "pages": 22,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1l014wptj4c.pdf",
    "summary": "<h3><strong>Westgold Resources Limited \u2013 June 2025 Quarterly Report (ASX: WGX)</strong></h3>\n<h4><strong>Key Takeaways for Capital Markets &amp; Trading:</strong></h4>\n<ol>\n<li><strong>Financial Highlights</strong>  </li>\n<li><strong>Record quarterly gold production</strong>: 88,022oz at AISC of <strong>$2,688/oz</strong>.  </li>\n<li><strong>Annual production</strong>: 326,384oz (missed guidance of 330\u2013350koz), AISC <strong>$2,666/oz</strong>.  </li>\n<li><strong>Revenue</strong>: <strong>$370M</strong> from gold sales (71,500oz at avg. price <strong>$5,174/oz</strong>).  </li>\n<li>\n<p><strong>Cash &amp; liquid assets</strong>: <strong>$364M</strong> (+$132M QoQ increase).  </p>\n</li>\n<li>\n<p><strong>Operations Update</strong>  </p>\n</li>\n<li><strong>Murchison region</strong>: 54,811oz (\u2191 from 42,906oz in Q3 FY25) driven by higher-grade stope access.  </li>\n<li>\n<p><strong>Southern Goldfields</strong>: 33,211oz (\u2193 from 37,201oz) due to trucking delays at Beta Hunt (~4koz deferred to FY26).  </p>\n</li>\n<li>\n<p><strong>Exploration &amp; Growth</strong>  </p>\n</li>\n<li><strong>Fletcher Zone (Beta Hunt) maiden resource</strong>: <strong>2.3Moz Au</strong> (31Mt @ 2.3g/t).  </li>\n<li>\n<p><strong>Exploration spend</strong>: <strong>$9M</strong> (focus on Beta Hunt, Bluebird-South Junction, Starlight).  </p>\n</li>\n<li>\n<p><strong>Capital Structure &amp; Liquidity</strong>  </p>\n</li>\n<li><strong>Debt</strong>: $50M drawn ($250M undrawn facility); total liquidity <strong>$614M</strong> (cash + undrawn debt).  </li>\n<li>\n<p><strong>Hedging</strong>: Fully unhedged to gold price.  </p>\n</li>\n<li>\n<p><strong>Divestment &amp; Synergies</strong>  </p>\n</li>\n<li><strong>Divestment plan</strong>: Targeting non-core assets (Comet, Paddy\u2019s Flat, etc.) in FY26.  </li>\n<li>\n<p><strong>Synergies realized</strong>: <strong>$54M/year</strong> (corporate savings, Lakewood sale).  </p>\n</li>\n<li>\n<p><strong>Outlook</strong>  </p>\n</li>\n<li><strong>FY26 guidance</strong>: To be released in August 2025.  </li>\n<li><strong>3-year outlook</strong>: Expected September 2025 post-resource update.  </li>\n</ol>\n<h4><strong>Material Catalysts Ahead</strong></h4>\n<ul>\n<li><strong>Beta Hunt expansion/resource conversion</strong> (Fletcher Zone).  </li>\n<li><strong>FY26 production guidance</strong> (August) and <strong>portfolio divestments</strong> (Q1 FY26).  </li>\n</ul>\n<p><em>No material capital raising or corporate action announced.</em>  </p>\n<p><strong>Priority Data</strong>: Cash build (+$132M), unhedged gold leverage, operational scalability, and high-grade resource growth.</p>",
    "usage": {
      "prompt_tokens": 12810,
      "completion_tokens": 553,
      "total_tokens": 13363,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:37:53.030804"
  },
  {
    "ticker": "LSF",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971690",
    "id": "02971690",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1l261z65htj.pdf",
    "summary": "<ul>\n<li><strong>NTA Update (18 July 2025)</strong>:  </li>\n<li><strong>NTA before tax</strong>: $3.3320 per share  </li>\n<li><strong>NTA after tax</strong>: $3.1775 per share  </li>\n</ul>\n<p><em>Note: Figures are unaudited and approximate.</em></p>",
    "usage": {
      "prompt_tokens": 442,
      "completion_tokens": 58,
      "total_tokens": 500,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:37:29.819585"
  },
  {
    "ticker": "HIQ",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971686",
    "id": "02971686",
    "pages": 4,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0818",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1ks1k6kp1mm.pdf",
    "summary": "<p><strong>No material information identified</strong>  </p>\n<p><em>(Note: This is a brand ambassador appointment announcement with no direct impact on capital structure, liquidity, valuation, or trading. Omitted as non-material for capital markets decisions.)</em></p>",
    "usage": {
      "prompt_tokens": 1327,
      "completion_tokens": 44,
      "total_tokens": 1371,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:36:01.915942"
  },
  {
    "ticker": "BUS",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971687",
    "id": "02971687",
    "pages": 14,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0818",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1kv4c6lxhkj.pdf",
    "summary": "<h3>Material Information Summary:</h3>\n<ul>\n<li><strong>Exploration Results</strong>:  </li>\n<li><strong>Key Findings</strong>:  <ul>\n<li>Strong chargeability anomalies identified via Induced Polarisation (IP) survey, analogous to Fosterville's high-grade gold zones.  </li>\n<li>Rock chip samples confirm gold (up to <strong>12.1 g/t</strong>) and antimony (up to <strong>2.02%</strong>).  </li>\n<li>Targets located <strong>15 km</strong> from Agnico Eagle's Fosterville Gold Mine.  </li>\n</ul>\n</li>\n<li><strong>Next Steps</strong>:  <ul>\n<li><strong>~1,000m diamond drilling</strong> planned for <strong>Q3 2025</strong> (5\u20136 holes) to test high-priority targets.  </li>\n</ul>\n</li>\n</ul>\n<p>No capital markets or trading-sensitive actions (e.g., capital raising, halts) identified. Focus is on exploratory progress.</p>",
    "usage": {
      "prompt_tokens": 5345,
      "completion_tokens": 167,
      "total_tokens": 5512,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:36:30.319235"
  },
  {
    "ticker": "MSV",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971688",
    "id": "02971688",
    "pages": 3,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0818",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1kx7pdj4nyx.pdf",
    "summary": "<h3><strong>Quarterly Investor Update Summary (Mitchell Services Limited \u2013 ASX: MSV)</strong></h3>\n<h4><strong>Key Financials (Q4 FY25 \u2013 Unaudited)</strong></h4>\n<ul>\n<li><strong>Revenue</strong>: $50.5m (\u21939.9% YoY)  </li>\n<li><strong>EBITDA</strong>: $7.7m (\u219321.9% YoY; margin 15.3%)  </li>\n<li><strong>Operating Cash Flow</strong>: $11.0m (143% EBITDA conversion)  </li>\n<li><strong>Net Debt</strong>: Reduced 40% to <strong>$8.4m</strong> (from $14.2m in Mar-25).  </li>\n</ul>\n<h4><strong>Operational Highlights</strong></h4>\n<ul>\n<li><strong>Disruptions</strong>: Temporary shutdowns at Oakey Creek (water ingress) and Moranbah North (gas incident) impacted Q4 performance. Resolved post-quarter.  </li>\n<li><strong>Loop Decarbonisation JV</strong>:  </li>\n<li>Completed first project successfully.  </li>\n<li>Received <strong>Letter of Intent (LOI)</strong> for second drilling services contract (late 2025 start).  </li>\n</ul>\n<h4><strong>FY25 Full-Year Summary</strong></h4>\n<ul>\n<li><strong>Revenue</strong>: $196.7m (\u219317% YoY).  </li>\n<li><strong>EBITDA</strong>: $25.7m (\u219336.4% YoY).  </li>\n<li><strong>Weaknesses</strong>: Lower rig counts (\u201312.8% YoY), coal sector softness.  </li>\n</ul>\n<h4><strong>Outlook</strong></h4>\n<ul>\n<li><strong>Gold Exposure</strong>: 45% of revenue; rising enquiries due to record gold prices.  </li>\n<li><strong>Coal Market</strong>: Contracts intact but rig demand down; positioned for recovery.  </li>\n<li><strong>Capital Return Hint</strong>: Share buyback likely given low share price.  </li>\n</ul>\n<p><strong>No material information omitted.</strong></p>",
    "usage": {
      "prompt_tokens": 2005,
      "completion_tokens": 350,
      "total_tokens": 2355,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:40:02.639513"
  },
  {
    "ticker": "RG8",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971685",
    "id": "02971685",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0818",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1kpyqqzz3s6.pdf",
    "summary": "<h3><strong>ASX Buy-Back Notification Summary</strong></h3>\n<ul>\n<li><strong>Entity:</strong> Regal Asian Investments Limited (RG8)  </li>\n<li><strong>Buy-Back Type:</strong> On-market  </li>\n<li><strong>Total Securities Bought Back (as of 22/7/2025):</strong> 4,861,122 (prior to previous day) + 13,055 (on previous day) = <strong>4,874,177 total</strong>  </li>\n<li><strong>Total Consideration Paid:</strong> AUD 9,645,610.04 (prior) + AUD 26,480.89 (previous day) = <strong>AUD 9,672,090.93 total</strong>  </li>\n<li><strong>Price Range (Previous Day):</strong> AUD 2.02 (low) \u2013 AUD 2.03 (high)  </li>\n<li><strong>Maximum Buy-Back Approved:</strong> 39,486,547 shares (remaining: <strong>34,612,370</strong>)  </li>\n<li><strong>Buy-Back Window:</strong> Estimated 26/11/2024 \u2013 24/11/2025  </li>\n</ul>\n<p><em>No further material information identified.</em></p>",
    "usage": {
      "prompt_tokens": 1562,
      "completion_tokens": 217,
      "total_tokens": 1779,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:35:03.452001"
  },
  {
    "ticker": "ORI",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971684",
    "id": "02971684",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0818",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1kmvxypxv2x.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type</strong>: On-market buy-back  </li>\n<li><strong>Total Buy-back Program</strong>: Up to <strong>$400 million</strong> of ordinary shares  </li>\n<li><strong>Buy-back Period</strong>: From <strong>28/3/2025</strong> to <strong>27/3/2026</strong>  </li>\n<li><strong>Shares Repurchased as of 22/7/2025</strong>: <strong>207,501</strong> (on previous day), <strong>9,608,091</strong> (cumulative)  </li>\n<li><strong>Total Consideration Paid</strong>: <strong>AUD 4.4 million</strong> (previous day), <strong>AUD 182.7 million</strong> (cumulative)  </li>\n<li><strong>Price Range</strong>: <strong>AUD 20.86\u201321.38</strong> (previous day), <strong>AUD 16.95\u201321.23</strong> (historical range)  </li>\n<li><strong>Broker</strong>: Goldman Sachs Australia Pty Ltd  </li>\n<li><strong>Conditionality</strong>: Subject to market conditions; may be varied/suspended.  </li>\n</ul>\n<p><em>No material changes to capital structure or liquidity beyond disclosed buy-back execution.</em></p>",
    "usage": {
      "prompt_tokens": 1578,
      "completion_tokens": 208,
      "total_tokens": 1786,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:39:03.288098"
  },
  {
    "ticker": "BTM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971680",
    "id": "02971680",
    "pages": 9,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0817",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1kckbs0pss6.pdf",
    "summary": "<h3><strong>Material Information from ASX Announcement (BTM \u2013 23 July 2025)</strong></h3>\n<h4><strong>1. Quarterly Activities Report Highlights</strong></h4>\n<ul>\n<li><strong>Errolls Gold Project acquisition completed</strong> (100% ownership secured on 10 June 2025).  </li>\n<li><strong>$1.2 million placement settled</strong> (17.4M shares issued @ $0.074/sh); cash balance <strong>$2.09M</strong> at 30 June 2025.  </li>\n<li><strong>Maiden RC drilling program approved</strong> (targeting high-grade gold extensions, assays expected September 2025 quarter).  </li>\n<li><strong>Maggie Hays Hill Project divested</strong> (received $100k stamp duty refund).  </li>\n</ul>\n<h4><strong>2. Capital Raising Details</strong></h4>\n<ul>\n<li><strong>Placement</strong>: $1.2M raised via issuance of 16.6M shares (sophisticated/institutional investors).  </li>\n<li><strong>Use of proceeds</strong>: Errolls exploration ($100k acquisition payment + drilling costs).  </li>\n</ul>\n<h4><strong>3. Financial Summary (Appendix 5B)</strong></h4>\n<ul>\n<li><strong>Cash outflow (quarter)</strong>: Operating: <strong>-$185k</strong>; Investing: <strong>-$188k</strong> (incl. $88k exploration).  </li>\n<li><strong>Funding runway</strong>: <strong>8 quarters</strong> based on current cash ($2.1M) vs. quarterly spend.  </li>\n</ul>\n<h4><strong>4. Key Upcoming Catalyst</strong></h4>\n<ul>\n<li><strong>Drilling commencement</strong> at Errolls (September 2025 quarter).  </li>\n</ul>\n<p><strong>Omissions</strong>: Non-material operational updates, director names, legal boilerplate.  </p>\n<p><em>(Summary tailored for trading/capital markets decisions.)</em></p>",
    "usage": {
      "prompt_tokens": 5016,
      "completion_tokens": 331,
      "total_tokens": 5347,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:38:52.178585"
  },
  {
    "ticker": "CBY",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971682",
    "id": "02971682",
    "pages": 17,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0817",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1khpxf91xcy.pdf",
    "summary": "<h3><strong>Canterbury Resources Limited (ASX: CBY) \u2013 Quarterly Report (30 June 2025) \u2013 Material Summary</strong></h3>\n<h4><strong>Key Operational Highlights:</strong></h4>\n<ul>\n<li><strong>Briggs Copper Project (QLD, 49% CBY):</strong>  </li>\n<li><strong>Scoping Study nearing completion</strong> (expected release in Sep-2025), assessing large-scale open-pit mine with potential for high copper recovery (94\u201395%) and low operating costs.  </li>\n<li><strong>Mineral Resource Estimate (MRE):</strong> 932Mt @ 0.21% Cu, 36ppm Mo, 0.6ppm Ag (2.0Mt Cu, 73Mlb Mo, 16.5Moz Ag).  </li>\n<li><strong>Upcoming drilling:</strong> 900m diamond hole (25BRD0037) to test deep VTEM target; 29 additional holes (8,000m) planned for 2025\u20132026 to expand MRE.  </li>\n<li>\n<p><strong>Funding:</strong> $250k grant from QLD govt. for drilling.  </p>\n</li>\n<li>\n<p><strong>Jack Shay Project (QLD, 100% CBY):</strong>  </p>\n</li>\n<li><strong>Acquisition completed</strong> for 5M shares + 5M options ($0.05 strike, Dec-2026 expiry).  </li>\n<li>\n<p><strong>Targets:</strong> Nerangy (Cu-Mo porphyry) and Red Hill (Ni-Cu-Co-Pt). Shallow air-core drilling planned.  </p>\n</li>\n<li>\n<p><strong>Morobe Project (PNG, 100% CBY):</strong>  </p>\n</li>\n<li>\n<p>Field work completed at Waits Creek (porphyry Cu) and Haiya Creek (Cu-Au skarn); 103 samples collected. Assays pending.  </p>\n</li>\n<li>\n<p><strong>Peenam Project (QLD, 100% CBY):</strong>  </p>\n</li>\n<li>Planning 4-hole (800m) drill program for Cu-Au porphyry target.  </li>\n</ul>\n<h4><strong>Financial Highlights (Appendix 5B):</strong></h4>\n<ul>\n<li><strong>Cash balance (30 Jun 2025):</strong> <strong>$0.69M</strong> (down from $0.91M last quarter).  </li>\n<li><strong>Quarterly cash outflow (operations):</strong> <strong>$0.30M</strong>.  </li>\n<li><strong>Financing:</strong> $0.13M raised via placement (5M shares @ $0.025).  </li>\n<li><strong>Debt:</strong> $0.3M (unsecured director loan, maturity Sep-2025).  </li>\n</ul>",
    "usage": {
      "prompt_tokens": 9833,
      "completion_tokens": 507,
      "total_tokens": 10340,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:39:54.596858"
  },
  {
    "ticker": "FPR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971678",
    "id": "02971678",
    "pages": 15,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0817",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1k7c694vz4g.pdf",
    "summary": "<p>Here\u2019s the material information extracted from the ASX announcement, formatted concisely:  </p>\n<h3><strong>FleetPartners Group (ASX:FPR) \u2013 3Q25 Business Update</strong></h3>\n<ul>\n<li><strong>AUMOF (Assets Under Management &amp; Ownership)</strong>  </li>\n<li>+5% YoY to <strong>$2.30bn</strong> (Jun-25).  </li>\n<li>\n<p>Balance sheet-funded AUMOF up <strong>13% YoY</strong> in Australia, <strong>23% YoY</strong> in Novated leasing.  </p>\n</li>\n<li>\n<p><strong>New Business Writings (NBW)</strong>  </p>\n</li>\n<li><strong>Total NBW down 17% YTD Jun-25</strong> (vs. prior year), impacted by:  <ul>\n<li>Accelerate system cutover disruption (2-week blackout).  </li>\n<li>Macroeconomic softness (e.g., NZ down 15% YoY).  </li>\n<li>Underlying decline ex-pipeline unwind/SLBs: <strong>-7%</strong>.  </li>\n</ul>\n</li>\n<li>\n<p><strong>Revised FY25 NBW outlook</strong>: Decline in line with 1H25 (vs. prior expectation of improvement to low double-digits).  </p>\n</li>\n<li>\n<p><strong>Financial Highlights</strong>  </p>\n</li>\n<li><strong>NOI pre-EOL &amp; provisions</strong>: +5% YTD Jun-25 vs. pcp.  </li>\n<li><strong>End-of-Lease (EOL) profit</strong>: <strong>$5,853/unit</strong> (3Q25); stabilization in used car prices expected to prolong stronger margins.  </li>\n<li>\n<p><strong>Cost savings</strong>: <strong>$6m+ annualized</strong> post-Accelerate implementation.  </p>\n</li>\n<li>\n<p><strong>Funding &amp; Liquidity</strong>  </p>\n</li>\n<li><strong>A$400m ABS issuance (Jul-25)</strong>: Class A notes priced at <strong>100bps</strong>, reducing cost of funds.  </li>\n<li>\n<p><strong>Undrawn warehouse capacity</strong>: <strong>A$250m</strong> post-ABS.  </p>\n</li>\n<li>\n<p><strong>Operational Disruptions (Temporary)</strong>  </p>\n</li>\n<li>Elevated arrears and net debt due to Accelerate cutover; resolution expected by <strong>FY25 results/1Q26</strong>.  </li>\n<li>\n<p>Novated leasing NBW down <strong>20% YoY</strong> (3Q25), but EV mix shifted to <strong>57% BEVs</strong>.  </p>\n</li>\n<li>\n<p><strong>Outlook</strong>  </p>\n</li>\n<li><strong>FY25 transition year</strong>; growth momentum expected from <strong>2H26</strong>.  </li>\n<li>Focus on underpenetrated markets (corporate fleets, EVs).  </li>\n</ul>\n<p><em>Omitted: Non-material operational details, forward-looking disclaimers, and branding commentary.</em></p>",
    "usage": {
      "prompt_tokens": 5155,
      "completion_tokens": 507,
      "total_tokens": 5662,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:34:52.100089"
  },
  {
    "ticker": "PLT",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971683",
    "id": "02971683",
    "pages": 5,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0817",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1kks43fryrq.pdf",
    "summary": "<h3><strong>1Q26 Trading Update - Material Information Summary</strong></h3>\n<ul>\n<li><strong>Record Loan Originations</strong>: $437 million (up 44% YoY, 7% QoQ)  </li>\n<li><strong>Loan Portfolio Growth</strong>: $2.7 billion (up 21% YoY, 6% QoQ)  </li>\n<li>Automotive: $1.51B (+20% YoY)  </li>\n<li>Renewable Energy: $356M (+23% YoY)  </li>\n<li>Personal: $809M (+24% YoY)  </li>\n<li><strong>Revenue</strong>: $73.3 million (up 20% YoY)  </li>\n<li><strong>Credit Performance</strong>:  </li>\n<li>Annualized net credit losses: 94 bps (vs. 116 bps prior quarter, 130 bps PCP)  </li>\n<li>90+ day arrears: 49 bps (up slightly from 43 bps last quarter)  </li>\n<li><strong>NAB Partnership</strong>:  </li>\n<li>NAB-powered auto loan originations up 110% QoQ; portfolio $38.7M (vs. $16.7M last quarter).  </li>\n<li><strong>WA Residential Battery Scheme</strong>: Won tender, launched tech solution by 1 July 2025.  </li>\n<li><strong>Funding</strong>: Completed $400M ABS issuance at 1.40% avg. margin (lower than prior issuance).  </li>\n<li><strong>FY26 Targets</strong>: On track for $3B loan book by Mar-2026 and $25M cost efficiencies.  </li>\n</ul>\n<p><em>Omitted: CEO commentary, historical breakdowns, non-material operational details.</em></p>",
    "usage": {
      "prompt_tokens": 2426,
      "completion_tokens": 324,
      "total_tokens": 2750,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:40:48.821677"
  },
  {
    "ticker": "A1M",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971679",
    "id": "02971679",
    "pages": 15,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0817",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1k9g200sl8p.pdf",
    "summary": "<p>Based on the investor presentation, here is the concise extraction of material information:</p>\n<p><strong>Key Financial &amp; Capital Metrics (as at 30 June 2025)</strong>\n- <strong>Cash balance:</strong> A$60.9M<br />\n- <strong>Debt:</strong> US$40M prepayment facility (undrawn)<br />\n- <strong>Market cap:</strong> A$229.9M (718.5M shares @ A$0.32)  </p>\n<p><strong>Operations Update</strong><br />\n- <strong>Eloise Mine (FY25 achieved):</strong><br />\n  - Production: 12,863t Cu, 5,955oz Au<br />\n  - AISC: US$3.24/lb Cu<br />\n  - Net cashflow: A$27.4M post-capital<br />\n- <strong>FY26 Guidance:</strong><br />\n  - Production: 12,800\u201313,100t Cu, 6,000\u20136,500oz Au<br />\n  - AISC: US$3.15\u2013US$3.40/lb Cu  </p>\n<p><strong>Jericho Development</strong><br />\n- <strong>Mineral Resource:</strong> 19.2Mt @ 2.0% Cu, 0.4g/t Au (381Kt Cu)<br />\n- <strong>Ore Reserve:</strong> 6.1Mt @ 1.8% Cu (108Kt Cu)<br />\n- <strong>Target:</strong> First ore June 2026; supports 20Ktpa Cu production target  </p>\n<p><strong>Plant Expansion</strong><br />\n- <strong>EPC contract:</strong> A$77.6M (fixed cost) awarded to GR Engineering<br />\n- <strong>Timeline:</strong> Construction starts Oct 2025, commissioning Q4 2026  </p>\n<p><strong>Exploration Focus</strong><br />\n- CY25: &gt;10,000m drilling at Jericho for resource growth.<br />\n- Combined Eloise Region Resources: 28.4Mt @ 2.0% Cu (563Kt Cu).  </p>\n<p><strong>Production Outlook (FY26\u2013FY28)</strong><br />\n- <strong>FY27 Target:</strong> 18,000\u201320,000t Cu (82% reserves, 18% inferred resources).  </p>\n<p><strong>Material Risks</strong><br />\n- Forward-looking targets rely on inferred resources (low geological confidence).  </p>\n<p><em>Omitted: General strategy, non-material operational details, and legal disclaimers.</em></p>",
    "usage": {
      "prompt_tokens": 5516,
      "completion_tokens": 462,
      "total_tokens": 5978,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:40:30.437129"
  },
  {
    "ticker": "LKE",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971681",
    "id": "02971681",
    "pages": 19,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0817",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1kfn5kbsfth.pdf",
    "summary": "<h3>Quarterly Cash Flow Report Summary (Appendix 5B)</h3>\n<ul>\n<li><strong>Cash Position</strong>:  </li>\n<li>Closing cash balance: <strong>$12.37 million</strong> (down from $15.15m last quarter).  </li>\n<li>Net cash used in operations: <strong>-$3.69m</strong> (quarter); <strong>-$25.78m</strong> (12-month).  </li>\n<li>Net proceeds from financing: <strong>$2.01m</strong> (ATM issuance of 56m shares at $0.04/share).  </li>\n<li>\n<p>Estimated funding runway: <strong>5.09 quarters</strong> (based on total available funding of $23.47m).  </p>\n</li>\n<li>\n<p><strong>Strategic Update</strong>:  </p>\n</li>\n<li>Special Committee evaluating alternatives (e.g., sale, merger, JV) for <strong>Kachi Lithium Project</strong>, citing undervaluation.  </li>\n<li>\n<p><strong>Goldman Sachs</strong> engaged to assist with strategic process.  </p>\n</li>\n<li>\n<p><strong>Operational Highlights</strong>:  </p>\n</li>\n<li><strong>Kachi Resource Upgrade</strong>: M&amp;I resources increased by <strong>10% to 8.2Mt LCE</strong>.  </li>\n<li><strong>DFS Addendum</strong> (Q3 2025 expected): Targets cost reductions (CAPEX/OPEX) via DLE tech optimizations.  </li>\n<li><strong>EIA Approval</strong>: Pending (anticipated 2H2025).  </li>\n<li>\n<p><strong>Power Supply</strong>: FEED study completed for grid power solution.  </p>\n</li>\n<li>\n<p><strong>Cost Management</strong>:  </p>\n</li>\n<li><strong>40% reduction</strong> in quarterly cash outgoings vs. prior quarter; full-year 2025 reduction target maintained at <strong>35\u201340%</strong>.  </li>\n</ul>\n<h3>Material Omissions:</h3>\n<ul>\n<li>No new debt or material changes to tenement status.  </li>\n<li>No exceptional operational disruptions disclosed.  </li>\n</ul>\n<p><strong>Summary</strong>: Liquidity stable with strategic options in play; execution risks remain tied to EIA approval and DFS outcomes.</p>",
    "usage": {
      "prompt_tokens": 10550,
      "completion_tokens": 374,
      "total_tokens": 10924,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:37:14.363489"
  },
  {
    "ticker": "NDO",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971677",
    "id": "02971677",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0817",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1k58xg867m6.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type</strong>: On-market  </li>\n<li><strong>Total Securities Bought Back (Previous Day)</strong>: 29,850  </li>\n<li><strong>Total Securities Bought Back (Cumulative)</strong>: 870,230  </li>\n<li><strong>Maximum Buy-back Program Size</strong>: 22,566,736 (remaining: 21,666,656)  </li>\n<li><strong>Previous Day Buy-back Details</strong>:  </li>\n<li>Total Consideration: AUD 19,999.50  </li>\n<li>Price Paid: AUD 0.67 (range: AUD 0.67\u20130.82)  </li>\n<li><strong>Program Duration</strong>: 14/3/2025\u201313/3/2026  </li>\n<li><strong>Broker</strong>: MA Moelis Australia Securities Pty Ltd  </li>\n<li><strong>No Shareholder Approval Required</strong></li>\n</ul>",
    "usage": {
      "prompt_tokens": 1499,
      "completion_tokens": 158,
      "total_tokens": 1657,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:36:50.910889"
  },
  {
    "ticker": "DNL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971675",
    "id": "02971675",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0816",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1k12rv4l5f5.pdf",
    "summary": "<h3><strong>Appendix 3C - Buy-back Notification Summary (DNL)</strong></h3>\n<ul>\n<li><strong>Type:</strong> On-market buy-back (no shareholder approval required).  </li>\n<li><strong>Total shares bought back (cumulative):</strong> 115,531,511.  </li>\n<li><strong>Shares bought on previous day (22/7/2025):</strong> 419,606.  </li>\n<li><strong>Total consideration paid (cumulative):</strong> AUD 336.8M.  </li>\n<li><strong>Previous day\u2019s buy-back cost:</strong> AUD 1.22M.  </li>\n<li><strong>Price range (previous day):</strong> AUD 2.90 (low) to AUD 2.92 (high).  </li>\n<li><strong>Buy-back window:</strong> 13/5/2025 to 28/11/2025.  </li>\n<li><strong>Program cap:</strong> Up to AUD 400M (no fixed share target).  </li>\n<li><strong>Broker:</strong> UBS Securities Australia.  </li>\n</ul>\n<p><em>No other material information.</em></p>",
    "usage": {
      "prompt_tokens": 1579,
      "completion_tokens": 194,
      "total_tokens": 1773,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:36:44.812650"
  },
  {
    "ticker": "AVM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971676",
    "id": "02971676",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0816",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1k35kqjz8tw.pdf",
    "summary": "<ul>\n<li><strong>Security Issuance</strong>: 1,716,174 new ordinary fully paid shares (ASX: AVM) issued on 22/07/2025.  </li>\n<li><strong>Issue Purpose</strong>: Signing fee for acquisition of the Guadalupe y Calvo Project.  </li>\n<li><strong>Issue Price</strong>: Estimated at AUD 0.043 per share.  </li>\n<li><strong>Post-Issue Capital</strong>:  </li>\n<li>Ordinary shares on issue: 266,751,008.  </li>\n<li>Total options/rights on issue: 193,628,802 (various expiry dates and exercise prices).  </li>\n<li><strong>No further securities to be issued</strong> for this transaction.  </li>\n</ul>\n<p><em>No other material information identified.</em></p>",
    "usage": {
      "prompt_tokens": 1484,
      "completion_tokens": 145,
      "total_tokens": 1629,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:38:56.077325"
  },
  {
    "ticker": "TTT",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971673",
    "id": "02971673",
    "pages": 12,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0816",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1jwy7mj2pkh.pdf",
    "summary": "<p><strong>Material Information Summary</strong>  </p>\n<ul>\n<li><strong>Employee Incentive Securities Issued (Unquoted)</strong>  </li>\n<li><strong>Zero-Strike Options</strong>: 13,786,500 vested in tranches (31-Dec-25, 31-Dec-26, 31-Dec-27) with share price performance hurdles ($0.33, $0.44, $0.77 for 15 days).  </li>\n<li><strong>Sign-on Rights</strong>:  <ul>\n<li>4,642,858 vesting 31-Dec-25 (US management).  </li>\n<li>1,250,000 vesting 21-Apr-26 (US management).  </li>\n</ul>\n</li>\n<li>\n<p><strong>$0.22-Strike Options</strong>:  </p>\n<ul>\n<li>6,250,000 vested in tranches (21-Apr-26, 21-Apr-27, 21-Apr-28).  </li>\n<li>23,214,286 vested in tranches (31-Dec-25, 31-Dec-26, 31-Dec-27).  </li>\n<li>1,250,000 vested in tranches (20-Jun-26, 20-Jun-27, 20-Jun-28).  </li>\n</ul>\n</li>\n<li>\n<p><strong>Key Management Personnel Allocations</strong>:  </p>\n</li>\n<li>Geoff Hollis: 6,900,000 zero-strike options.  </li>\n<li>Klaas Rozema: 6,000,000 zero-strike options.  </li>\n<li>\n<p>Patricia Dare: 11,607,143 $0.22-strike options + 2,321,429 sign-on rights.  </p>\n</li>\n<li>\n<p><strong>Post-Issue Capital Structure</strong>:  </p>\n</li>\n<li>Ordinary shares (TTT): 1,325,758,397 (quoted).  </li>\n<li>Unquoted securities include options/rights totaling ~221M (details in Part 4.2).  </li>\n</ul>\n<p><strong>No material trading/capital raising impact (employee incentive issuance only).</strong></p>",
    "usage": {
      "prompt_tokens": 5379,
      "completion_tokens": 387,
      "total_tokens": 5766,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:36:11.845111"
  },
  {
    "ticker": "MEU",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971672",
    "id": "02971672",
    "pages": 10,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0816",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1jtvggn04rx.pdf",
    "summary": "<h3>Summary:</h3>\n<ul>\n<li><strong>Drilling Program Expansion</strong>: Maiden drilling program at Greenewood expanded from <strong>10,000m to ~12,500m</strong>, increasing planned holes from <strong>127 to 139</strong>.  </li>\n<li><strong>Progress</strong>: <strong>61 holes (5,108m)</strong> already drilled in July; drilling to continue for <strong>4\u20135 weeks</strong>.  </li>\n<li><strong>Gold Price Context</strong>: Current gold price (~A$5,200/oz) is <strong>3x higher</strong> than during last drilling in 2018 (~A$1,600/oz).  </li>\n<li><strong>Ownership</strong>: Marmota holds <strong>90% interest</strong> in Greenewood via Golden Moon JV.  </li>\n<li><strong>Strategic Location</strong>: Greenewood is <strong>~35km NW</strong> of Marmota\u2019s flagship Aurora Tank deposit.  </li>\n</ul>\n<p><em>No material capital markets or trading actions (e.g., capital raising, halts) identified.</em></p>",
    "usage": {
      "prompt_tokens": 2003,
      "completion_tokens": 186,
      "total_tokens": 2189,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:35:39.540867"
  },
  {
    "ticker": "NGY",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971674",
    "id": "02971674",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0816",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1jyzzv1h5hc.pdf",
    "summary": "<p><strong>Key Material Information:</strong>  </p>\n<ul>\n<li><strong>Successful drilling completion</strong> of second CBM well (TE-B06-002) in Tanjung Enim POD 1 (South Sumatra), targeting initial gas sales of <strong>1 mmscfd</strong> (Indonesia\u2019s first commercial CBM development).  </li>\n<li><strong>Intersected five coal seams</strong> (47.3m cumulative thickness) with confirmed gas presence.  </li>\n<li><strong>Progressive Cavity Pump (PCP) installed</strong> with real-time monitoring, enhancing production stability and efficiency.  </li>\n<li><strong>Gas delivery agreement</strong> with PT Perusahaan Gas Negara (PGN) via infield pipeline for all four planned wells.  </li>\n<li><strong>Drilling rig mobilized</strong> to third well site; dewatering ongoing (from 22 July 2025).  </li>\n</ul>\n<p><em>No capital raising, financial data, or trading halt details identified.</em></p>",
    "usage": {
      "prompt_tokens": 1140,
      "completion_tokens": 173,
      "total_tokens": 1313,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:39:29.529569"
  },
  {
    "ticker": "SLF",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971611",
    "id": "02971611",
    "pages": 4,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0810",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1dr7ztldcjl.pdf",
    "summary": "<ul>\n<li><strong>Fund NAV</strong>: $13.93 per unit (as of 22-July-2025).  </li>\n<li><strong>Creation Unit Value</strong>: $696,330.00.  </li>\n<li><strong>Total Fund NAV</strong>: $572,382,529.06.  </li>\n<li><strong>Units Outstanding</strong>: 41,100,001 (no change from previous day).  </li>\n<li><strong>Underlying Holdings</strong>: 20 ASX-listed property securities, with largest exposures to Scentre Group (SCG, 20,901 units), Mirvac Group (MGR, 15,834 units), and Vicinity Centres (VCX, 15,564 units).  </li>\n</ul>\n<p><em>Note: Routine daily ETF NAV and holdings update; no material capital markets or trading-impacting changes.</em></p>",
    "usage": {
      "prompt_tokens": 1533,
      "completion_tokens": 155,
      "total_tokens": 1688,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:12:21.905551"
  },
  {
    "ticker": "BMO",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971607",
    "id": "02971607",
    "pages": 1,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0810",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1dgydf8xfld.pdf",
    "summary": "<ul>\n<li><strong>Legal Dispute Settlement</strong>: Bastion Minerals (ASX:BMO) and GTT Ventures (former advisor/broker) have mutually settled their dispute.  </li>\n<li><strong>Writ Withdrawn</strong>: GTT has withdrawn the Writ of Summons filed against the Company.  </li>\n</ul>\n<p><em>No material financial or trading impact identified.</em></p>",
    "usage": {
      "prompt_tokens": 431,
      "completion_tokens": 67,
      "total_tokens": 498,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:12:26.994246"
  },
  {
    "ticker": "RPG",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971613",
    "id": "02971613",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0810",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1dwf1vjyyf2.pdf",
    "summary": "<ul>\n<li><strong>Proposed Change of Company Name</strong>: Raptis Group Limited (ASX:RPG) to Group One Capital Limited.  </li>\n<li><strong>Effective Date</strong>: Post-shareholder approval at next meeting.  </li>\n<li><strong>No Material Impact</strong>: No effect on legal status, rights/obligations, operations, or financial position.  </li>\n</ul>\n<p><em>No material trading or capital markets impact identified.</em></p>",
    "usage": {
      "prompt_tokens": 528,
      "completion_tokens": 78,
      "total_tokens": 606,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:12:24.816430"
  },
  {
    "ticker": "ZMM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971609",
    "id": "02971609",
    "pages": 5,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0810",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1dm3ghsmk92.pdf",
    "summary": "<p>Understood. Please provide the ASX announcement PDF (or its text), and I will extract only the material information relevant for trading or capital markets decisions, formatted as concise bullet points per your specified guidelines.  </p>\n<p>If the document is unclear or lacks material details, I will note: <strong>\"No material information identified.\"</strong>  </p>\n<p>Examples of how I will structure outputs:  </p>\n<ul>\n<li><strong>Trading Halt Request</strong>: \"Halt requested pending release of capital raising details.\"  </li>\n<li><strong>Capital Raising Announcement</strong>: \"Placement to raise AUD 50M; Ex-date: 15 Oct, Record date: 18 Oct, Close date: 25 Oct.\"  </li>\n<li><strong>Quarterly Report (4C)</strong>: \"Cash balance AUD 12.5M; Quarterly cash burn AUD 1.2M; Key milestone: Phase 2 trial enrollment completed.\"  </li>\n<li><strong>Other Announcement</strong>: \"Strategic acquisition of [Target] for AUD 100M; Funding via AUD 70M equity + AUD 30M debt.\"  </li>\n</ul>\n<p>Provide the document, and I\u2019ll proceed.</p>",
    "usage": {
      "prompt_tokens": 240,
      "completion_tokens": 219,
      "total_tokens": 459,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:12:53.511271"
  },
  {
    "ticker": "DKM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971608",
    "id": "02971608",
    "pages": 11,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0810",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1dk172qnb3l.pdf",
    "summary": "<h3><strong>Material Information Summary</strong></h3>\n<h4><strong>Drilling Update \u2013 Killarney Gold Project</strong></h4>\n<p>intrigued<br />\n<strong>Territory Alliance</strong><br />\n- <strong>Drilling Program</strong>:<br />\n  - 17 RC holes completed (1,716m total).<br />\n  - Deepest hole: 148m; all holes reached target depths with high recovery.<br />\n- <strong>Geological Observations</strong>:<br />\n  - Shallow surface weathering transitions into fresh metamorphosed gabbro.<br />\n  - Quartz veining and weathered zones identified down-plunge from historical pit.<br />\n- <strong>Assays Pending</strong>: Results expected in <strong>4\u20136 weeks</strong>.  </p>\n<p><strong>Note</strong>: No assay results or resource estimates disclosed; market update pending lab results.  </p>\n<p><strong>Brevity Key</strong>: Focused on actionable data (drilling scale, timing for assays). Omitted JORC details, maps, and historical context as non-material for immediate trading.</p>",
    "usage": {
      "prompt_tokens": 4692,
      "completion_tokens": 186,
      "total_tokens": 4878,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:12:47.451262"
  },
  {
    "ticker": "STW",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971612",
    "id": "02971612",
    "pages": 9,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0810",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1dtb833xh0g.pdf",
    "summary": "<p><strong>SPDR\u00ae S&amp;P\u00ae/ASX 200 Fund (STW) - Daily Fund Update (23-July-2025)</strong>  </p>\n<ul>\n<li><strong>NAV per Unit</strong>: $77.96  </li>\n<li><strong>Total Fund NAV</strong>: $6,087,844,973.53  </li>\n<li><strong>Units Outstanding</strong>: 78,088,517 (no change from previous day).  </li>\n<li><strong>Trade Date</strong>: 22-July-2025 (data reflects prior day close).  </li>\n</ul>\n<p><strong>No material changes</strong> to capital structure, liquidity, or trading dynamics identified. Routine daily update with standard NAV disclosure.  </p>\n<p><em>Note: No actionable capital markets or trading insights; operational metrics are unchanged.</em></p>",
    "usage": {
      "prompt_tokens": 3808,
      "completion_tokens": 140,
      "total_tokens": 3948,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:12:41.381906"
  },
  {
    "ticker": "SFY",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971610",
    "id": "02971610",
    "pages": 4,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0810",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1dp5qjbcc24.pdf",
    "summary": "<p>No material information identified.  </p>\n<p><em>(Note: This is a routine daily NAV update for an ETF, containing no material corporate actions, capital changes, or trading-sensitive information.)</em></p>",
    "usage": {
      "prompt_tokens": 1841,
      "completion_tokens": 36,
      "total_tokens": 1877,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:13:07.358830"
  },
  {
    "ticker": "SCG",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971606",
    "id": "02971606",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250723",
    "time": "0804",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1dclr0jxw4h.pdf",
    "summary": "<p>Understood. Provide the ASX announcement PDF or the key details (company name, announcement type, headline), and I\u2019ll extract <strong>only material information</strong> in the format you\u2019ve specified.  </p>\n<p>Example outputs:  </p>\n<p><strong>Trading Halt Request:</strong><br />\n- <em>Reason</em>: Pending release of capital raising details.  </p>\n<p><strong>Capital Raising (Placement + SPP):</strong><br />\n- <em>Structure</em>: AUD 50M Placement (institutional) + AUD 10M SPP.<br />\n- <em>Key dates</em>: Ex-date 15 Oct, Record 18 Oct, SPP Close 30 Oct.  </p>\n<p><strong>Appendix 4C (Quarterly):</strong><br />\n- <em>Cash balance</em>: AUD 2.1M (prior quarter: AUD 3.4M).<br />\n- <em>Highlight</em>: Sales up 22% QoQ to AUD 5.7M.  </p>\n<p><strong>Other Announcement:</strong><br />\n- <em>Material impact</em>: Major offtake agreement signed (10x current production volume).<br />\n- <em>Condition</em>: Subject to final approvals (expected Q3 2024).  </p>\n<p>If the announcement is irrelevant (e.g., director resignation without rationale), I\u2019ll note:<br />\n- <em>No material information identified</em>.  </p>\n<p>Please share the document or specifics. I\u2019ll adhere strictly to your rules.</p>",
    "usage": {
      "prompt_tokens": 225,
      "completion_tokens": 273,
      "total_tokens": 498,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:13:00.511931"
  },
  {
    "ticker": "TWR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971604",
    "id": "02971604",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250723",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1d0csgz5tv1.pdf",
    "summary": "<ul>\n<li><strong>Key Announcement:</strong> Tower Limited (TWR) will discontinue multi-policy discounts.  </li>\n<li><strong>Reason:</strong> Complexity in accurate discount application creates regulatory and customer experience risks.  </li>\n</ul>\n<p>No material financial or capital markets impact identified.</p>",
    "usage": {
      "prompt_tokens": 541,
      "completion_tokens": 48,
      "total_tokens": 589,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-22T22:12:31.950410"
  }
]